201 related articles for article (PubMed ID: 33949025)
21. Corticotropin-releasing factor infusion into nucleus incertus suppresses medial prefrontal cortical activity and hippocampo-medial prefrontal cortical long-term potentiation.
Farooq U; Rajkumar R; Sukumaran S; Wu Y; Tan WH; Dawe GS
Eur J Neurosci; 2013 Aug; 38(4):2516-25. PubMed ID: 23668693
[TBL] [Abstract][Full Text] [Related]
22. A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.
Schmeichel BE; Zemlan FP; Berridge CW
Neuropharmacology; 2013 Jan; 64(1):321-8. PubMed ID: 22796428
[TBL] [Abstract][Full Text] [Related]
23. Corticotropin-releasing factor signaling and its potential role in the prefrontal cortex-dependent regulation of anxiety.
Yang X; Geng F
J Neurosci Res; 2023 Dec; 101(12):1781-1794. PubMed ID: 37592912
[TBL] [Abstract][Full Text] [Related]
24. Sex-specific alterations in corticotropin-releasing factor regulation of coerulear-cortical network activity.
Bates MLS; Arner JR; Curtis AL; Valentino R; Bhatnagar S
Neuropharmacology; 2023 Feb; 223():109317. PubMed ID: 36334761
[TBL] [Abstract][Full Text] [Related]
25. Stress during a critical postnatal period induces region-specific structural abnormalities and dysfunction of the prefrontal cortex via CRF1.
Yang XD; Liao XM; Uribe-Mariño A; Liu R; Xie XM; Jia J; Su YA; Li JT; Schmidt MV; Wang XD; Si TM
Neuropsychopharmacology; 2015 Mar; 40(5):1203-15. PubMed ID: 25403725
[TBL] [Abstract][Full Text] [Related]
26. Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex.
Durstewitz D; Seamans JK; Sejnowski TJ
J Neurophysiol; 2000 Mar; 83(3):1733-50. PubMed ID: 10712493
[TBL] [Abstract][Full Text] [Related]
27. Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility.
Snyder K; Wang WW; Han R; McFadden K; Valentino RJ
Neuropsychopharmacology; 2012 Jan; 37(2):520-30. PubMed ID: 21993205
[TBL] [Abstract][Full Text] [Related]
28. The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex.
Spencer RC; Devilbiss DM; Berridge CW
Biol Psychiatry; 2015 Jun; 77(11):940-50. PubMed ID: 25499957
[TBL] [Abstract][Full Text] [Related]
29. Amelioration of cognitive impairments induced by GABA hypofunction in the male rat prefrontal cortex by direct and indirect dopamine D
Auger ML; Meccia J; Phillips AG; Floresco SB
Neuropharmacology; 2020 Jan; 162():107844. PubMed ID: 31704272
[TBL] [Abstract][Full Text] [Related]
30. Corticotropin releasing factor impairs sustained attention in male and female rats.
Cole RD; Kawasumi Y; Parikh V; Bangasser DA
Behav Brain Res; 2016 Jan; 296():30-34. PubMed ID: 26306826
[TBL] [Abstract][Full Text] [Related]
31. Prefrontal Cortex Corticotropin-Releasing Factor Receptor 1 Conveys Acute Stress-Induced Executive Dysfunction.
Uribe-Mariño A; Gassen NC; Wiesbeck MF; Balsevich G; Santarelli S; Solfrank B; Dournes C; Fries GR; Masana M; Labermeier C; Wang XD; Hafner K; Schmid B; Rein T; Chen A; Deussing JM; Schmidt MV
Biol Psychiatry; 2016 Nov; 80(10):743-753. PubMed ID: 27318500
[TBL] [Abstract][Full Text] [Related]
32. Functional Interplay of Type-2 Corticotrophin Releasing Factor and Dopamine Receptors in the Basolateral Amygdala-Medial Prefrontal Cortex Circuitry.
Yarur HE; Zegers J; Vega-Quiroga I; Novoa J; Ciruela F; Andres ME; Gysling K
Int J Neuropsychopharmacol; 2021 Mar; 24(3):221-228. PubMed ID: 33125479
[TBL] [Abstract][Full Text] [Related]
33. A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety.
Pomrenze MB; Tovar-Diaz J; Blasio A; Maiya R; Giovanetti SM; Lei K; Morikawa H; Hopf FW; Messing RO
J Neurosci; 2019 Feb; 39(6):1030-1043. PubMed ID: 30530860
[TBL] [Abstract][Full Text] [Related]
34. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness.
Devilbiss DM; Berridge CW
Biol Psychiatry; 2008 Oct; 64(7):626-35. PubMed ID: 18585681
[TBL] [Abstract][Full Text] [Related]
35. Effects of chronic noise on mRNA and protein expression of CRF family molecules and its relationship with p-tau in the rat prefrontal cortex.
Gai Z; Li K; Sun H; She X; Cui B; Wang R
J Neurol Sci; 2016 Sep; 368():307-13. PubMed ID: 27538655
[TBL] [Abstract][Full Text] [Related]
36. Episodic Social Stress-Escalated Cocaine Self-Administration: Role of Phasic and Tonic Corticotropin Releasing Factor in the Anterior and Posterior Ventral Tegmental Area.
Holly EN; Boyson CO; Montagud-Romero S; Stein DJ; Gobrogge KL; DeBold JF; Miczek KA
J Neurosci; 2016 Apr; 36(14):4093-105. PubMed ID: 27053215
[TBL] [Abstract][Full Text] [Related]
37. Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety.
Sink KS; Walker DL; Freeman SM; Flandreau EI; Ressler KJ; Davis M
Mol Psychiatry; 2013 Mar; 18(3):308-19. PubMed ID: 22290119
[TBL] [Abstract][Full Text] [Related]
38. Corticotropin releasing factor in the nucleus basalis of Meynert impairs attentional performance and reduces levels of glutamate and taurine in male and female rats.
Eck SR; Kokras N; Wicks B; Baltimas P; Hall A; van Bendegem N; Salvatore M; Cohen SR; Bergmann J; Ceretti A; Parikh V; Dalla C; Bangasser DA
Neuropharmacology; 2022 Dec; 221():109280. PubMed ID: 36216029
[TBL] [Abstract][Full Text] [Related]
39. Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior.
Meloni EG; Reedy CL; Cohen BM; Carlezon WA
Biol Psychiatry; 2008 May; 63(9):832-9. PubMed ID: 18061145
[TBL] [Abstract][Full Text] [Related]
40. NR2A-Containing NMDARs in the Prefrontal Cortex Are Required for Working Memory and Associated with Age-Related Cognitive Decline.
McQuail JA; Beas BS; Kelly KB; Simpson KL; Frazier CJ; Setlow B; Bizon JL
J Neurosci; 2016 Dec; 36(50):12537-12548. PubMed ID: 27807032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
